The effects of progesterone on the alpha2-adrenergic receptor subtypes in late-pregnant uterine contractions in vitro
Open Access
- 14 June 2016
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 14 (1) , 1-9
Abstract
The adrenergic system and progesterone play major roles in the control of the uterine function. Our aims were to clarify the changes in function and expression of the α2-adrenergic receptor (AR) subtypes after progesterone pretreatment in late pregnancy. Sprague Dawley rats from pregnancy day 15 were treated with progesterone for 7 days. The myometrial expressions of the α2-AR subtypes were determined by RT-PCR and Western blot analysis. In vitro contractions were stimulated with (−)-noradrenaline, and its effect was modified with the selective antagonists BRL 44408 (α2A), ARC 239 (α2B/C) and spiroxatrine (α2A). The accumulation of myometrial cAMP was also measured. The activated G-protein level was investigated via GTPγS binding assays. Progesterone pretreatment decreased the contractile effect of (−)-noradrenaline through the α2-ARs. The most significant reduction was found through the α2B-ARs. The mRNA of all of the α2-AR subtypes was increased. Progesterone pretreatment increased the myometrial cAMP level in the presence of BRL 44408 (p < 0.001), spiroxatrine (p < 0.001) or the spiroxatrine + BRL 44408 combination (p < 0.05). Progesterone pretreatment increased the G-protein-activating effect of (−)-noradrenaline in the presence of the spiroxatrine + BRL 44408 combination. The expression of the α2-AR subtypes is progesterone-sensitive. It decreases the contractile response of (−)-noradrenaline through the α2B-AR subtype, blocks the function of α2A-AR subtype and alters the G protein coupling of these receptors, promoting a Gs-dependent pathway. A combination of α2C-AR agonists and α2B-AR antagonists with progesterone could be considered for the treatment or prevention of preterm birth.Keywords
Funding Information
- Hungarian National Research, Development and Innovation Office (OTKA-108518)
This publication has 33 references indexed in Scilit:
- Calcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic CombinationsPharmaceuticals, 2013
- α2-Adrenoceptor subtypes-mediated physiological, pharmacological actionsNeurochemistry International, 2009
- Modification of the effect of nifedipine in the pregnant rat myometrium: The influence of progesterone and terbutalineLife Sciences, 2009
- Gestagen treatment enhances the tocolytic effect of salmeterol in hormone-induced preterm labor in the rat in vivoAmerican Journal of Obstetrics and Gynecology, 2008
- Different roles of α2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the ratNeurochemistry International, 2007
- α2-Adrenoceptor subtypes—Unexpected functions for receptors and ligands derived from gene-targeted mouse modelsNeurochemistry International, 2007
- Alpha-adrenoceptor subtypesPharmacological Research, 2001
- Differential effects of antisense oligodeoxynucleotides directed against Gzα and Goα on antinociception produced by spinal opioid and α2 adrenergic receptor agonistsPain, 2000
- Pregnancy switches adrenergic signal transduction in rat and human uterine myocytes as probed by BKCa channel activityThe Journal of Physiology, 2000
- Heterogeneity of α2‐adrenoceptors in human and rat myometrium and differential expression during pregnancyBritish Journal of Pharmacology, 1997